Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Justice
Cardiovascular Risk and COX-2 Inhibition in Rheumatological Practice
Journal of Human Hypertension
Internal Medicine
Related publications
Cardiovascular Safety of COX-2 Inhibition: Time to Inform Systems of Postmarketing Surveillance?
Therapy
Viscum Album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA
PLoS ONE
Multidisciplinary
Inducible COX-2 Dominates Over COX-1 in Prostacyclin Biosynthesis: Mechanisms of COX-2 Inhibitor Risk to Heart Disease
Life Sciences
Genetics
Molecular Biology
Pharmacology
Biochemistry
Medicine
Toxicology
Pharmaceutics
Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Screening for Cardiovascular Risk in General Practice
BMJ
COX-2 Gene Promoter Haplotypes and Prostate Cancer Risk
Carcinogenesis
Medicine
Cancer Research
Reduction in Cancer Risk by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors
Journal of Experimental Pharmacology
Molecular Medicine
Pharmacology
COX-2 Inhibition, Apoptosis, and Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs.
Current Medicinal Chemistry
Organic Chemistry
Biochemistry
Drug Discovery
Molecular Medicine
Pharmacology
COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors
Gut
Gastroenterology